Linden and DW Healthcare Partners Complete HydraFacial s Public Offering via SPAC Merger
News provided by
Share this article
Share this article
CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ Linden Capital Partners ( Linden ) and DW Healthcare Partners IV, LP ( DW Healthcare Partners ), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ( HydraFacial ), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) ( Vesper or Vesper Healthcare ). Vesper is a special purpose acquisition company ( SPAC ) led by former Allergan CEO Brent Saunders. As a result of the transaction, the combined company, now known as The Beauty Health Company ( BeautyHealth or the Company ), is expected to trade on the Nasdaq Stock Market under the ticker symbol SKIN beginning May 6, 2021. Linden will remain BeautyHealth s largest shareholder.
DW Healthcare Partners Invests in Parnell
News provided by
Share this article
Share this article
PARK CITY, Utah, Feb. 1, 2021 /PRNewswire/ DW Healthcare Partners ( DWHP ) a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) ( Parnell or the Company ). Founded over 50 years ago in Australia, Parnell is a fully integrated manufacturer and developer of animal health pharmaceuticals focused on the US market. Parnell has an attractive position with an FDA approved manufacturing facility dedicated to animal health drugs with a particular focus on sterile injectables, said Eric Moore, Principal at DWHP. Alan and Brad have done a great job building a quality and compliance culture at the Company and over the last three years have dramatically transformed the organization. We look forward to helping them accelerate growth in the coming years.
Notice of Annual General Meeting and Explanatory Memorandum saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Parnell Pharmaceuticals Holdings: Notice of Annual General Meeting and Explanatory Memorandum
SYDNEY, AUSTRALIA / ACCESSWIRE / January 22, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Thursday, 4th March 2021 at 9:00 a.m. (Australian Eastern Standard Time).
NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM
Notice is given that the Annual General Meeting of shareholders of Parnell Pharmaceuticals Holdings Ltd (Company) will be held on:
Thursday, 4th March 2021 at 9:00 a.m. (Australian Eastern Standard Time)
The meeting is to be held in person at the Company s headquarters: First Floor, Unit 4, 476 Gardners Road, Alexandria NSW, 2015, Australia
DW Healthcare Partners and Linden Announce Sale of Z-Medica to Teleflex marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.